ConvaTec Group Plc - Company Profile
Powered by 
All the sales intelligence you need on ConvaTec Group Plc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how ConvaTec Group Plc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with ConvaTec Group Plc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
ConvaTec Group PLC (ConvaTec) is a global medical products and technologies company focused on therapies for managing chronic conditions. The company's main activities include the development and provision of advanced wound care, ostomy care, continence and critical care, and infusion devices. Its major products include wound dressings, skin care products, disposable infusion sets, urological catheters, and devices and accessories for people with ostomy, urinary continence, spinal cord injuries, diabetes, ulcers, multiple sclerosis, spina bifida, and other disorders. ConvaTec offers products to hospitals, home care agencies, pharmacies, insulin pump manufacturers and retail distributors in the home care market directly and through a network of distributors. The company's products serve patients with chronic conditions, their families, caregivers, and healthcare professionals, addressing needs in areas such as diabetes, colorectal cancer, and neurological diseases. The company has a presence in the Americas, Asia Pacific, Europe, the Middle East, and Africa. ConvaTec is headquartered in London, England, the UK.
Headquarters
United Kingdom
Address
7th Floor, 20 Eastbourne Terrace, London, Greater London, W26LG
Website
www.convatecgroup.com
No of Employees
10,903
Industry
Medical Equipment
Ticker Symbol & Exchange
CTEC (LON)
Revenue (2024)
$2.4B
6.5%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
-8.1%
(2024 vs 2023)
Market Cap*
$5.7B
Net Profit Margin (2024)
XYZ
-13.7%
(2024 vs 2023)
* As of and is in US$
ConvaTec Group Plc premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Ostomy Care: | AQUACEL |
| Adhesive Remover Wipes | AQUACEL Ag+ |
| Other Products | AQUACEL Ag Foam |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2025 | Contracts/Agreements | In November, the company selected LTIMindtree for the implementation of SAP’s Digital Core – S/4HANA across its business operations. |
| 2025 | Regulatory Approval | In July, the company received clearance for Aquacel ConvaFiber, a next-generation dressing for managing a range of wounds. |
| 2025 | Contracts/Agreements | In October, the company collaborates with AbbVie for VYALEV therapy for the treatment of advanced Parkinson’s disease in the United States. |
Competitor Comparison
| Key Parameters | ConvaTec Group Plc | Medline Industries LP | Stryker Corp | Smith & Nephew Plc | Ypsomed Holding AG |
|---|---|---|---|---|---|
| Headquarters | United Kingdom | United States of America | United States of America | United Kingdom | Switzerland |
| City | London | Northfield | Portage | Watford | Burgdorf |
| State/Province | Greater London | Illinois | Michigan | England | - |
| No. of Employees | 10,903 | 45,000 | 56,000 | 16,988 | 2,753 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| John McAdam | Chairman | Executive Board | 2019 | - |
| Jonny Mason | Chief Executive Officer; Director | Executive Board | 2025 | - |
| Fiona Ryder | Chief Financial Officer; Director | Executive Board | 2025 | - |
| Divakar Ramakrishnan | Chief Technology Officer; Executive Vice President; Head - Research & Development | Senior Management | 2020 | - |
| John Haller | Chief - Quality & Operations Officer; Executive Vice President | Senior Management | 2022 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer